Nexkin Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Nexkin General Information
Description
Developer of a medical device and technology designed to automate the skin prick allergy test. The company's device assists in improving skin prick tests in a precise and fast manner with minimal manual tasks, enabling laboratories and hospitals to collect all the information stored in digital format, and further facilitating the statistical study.
Contact Information
Website
nexkinmedical.comCorporate Office
- Paseo de Miramón 170
- 20014 San Sebastian
- Spain
Corporate Office
- Paseo de Miramón 170
- 20014 San Sebastian
- Spain
Nexkin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Equity Crowdfunding | 06-Mar-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 11-May-2022 | Completed | Generating Revenue | |||
| 4. Grant | 31-Oct-2018 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 10-Oct-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Oct-2017 | $182K | $273K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 26-Jan-2017 | $90.1K | $90.1K | Completed | Generating Revenue |
Nexkin Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nexkin Patents
Nexkin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4815814-A1 | Computer implemented method for detecting and optionally measuring at least one protuberance | Pending | 01-Dec-2023 | ||
| WO-2025114372-A1 | Computer implemented method for detecting and optionally measuring at least one protuberance | Inactive | 01-Dec-2023 | ||
| US-20240122527-A1 | Method and system for detecting and optionally measuring at least one dimension of one or more protuberances of an area of a skin surface | Inactive | 18-Oct-2022 | ||
| EP-4356820-A1 | Method and system for detecting and optionally measuring at least one dimension of one ore more protuberances of an area of a skin surface | Pending | 18-Oct-2022 | ||
| US-D944994-S1 | Medical device for diagnosing allergies and obtaining skin surface characteristics | Active | 28-Feb-2020 |
Nexkin Signals
Nexkin Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Geroa Pentsioak | Limited Partner | Minority |
Nexkin FAQs
-
When was Nexkin founded?
Nexkin was founded in 2016.
-
Where is Nexkin headquartered?
Nexkin is headquartered in San Sebastian, Spain.
-
What is the size of Nexkin?
Nexkin has 12 total employees.
-
What industry is Nexkin in?
Nexkin’s primary industry is Diagnostic Equipment.
-
Is Nexkin a private or public company?
Nexkin is a Private company.
-
What is Nexkin’s current revenue?
The current revenue for Nexkin is .
-
How much funding has Nexkin raised over time?
Nexkin has raised $2.4M.
-
Who are Nexkin’s investors?
Geroa Pentsioak has invested in Nexkin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process